European Commission (EC) — Cosmetics · European Union
EU Cosmetics Regulation 1223/2009
EU cosmetic claims in labelling and advertising must be truthful, supported and fair under Reg. 655/2013, may not claim to treat disease, and labels must carry the Art. 19 information.
EU cosmetic claims in labelling and advertising must be truthful, supported and fair under Reg. 655/2013, may not claim to treat disease, and labels must carry the Art. 19 information. Ads, product pages, social posts and labels for cosmetic products sold in the EU.
EU cosmetic claims in labelling and advertising must be truthful, supported and fair under Reg. 655/2013, may not claim to treat disease, and labels must carry the Art. 19 information.
How can marketing teams comply?
Ads, product pages, social posts and labels for cosmetic products sold in the EU.
EU cosmetic claims in labelling and advertising must be truthful, supported and fair under Reg. 655/2013, may not claim to treat disease, and labels must carry the Art. 19 information.
Program marketing at Title IV institutions must not misrepresent graduate earnings or outcomes, and programs warned under the Gainful Employment rule must give the required student warning; rule status is in flux after the 2025 budget law.
REACH governs chemicals in EU products; in marketing, chemical free-from and REACH-status claims must be accurate and not misleading, and REACH compliance may not be presented as a distinctive benefit.
The FTC Act bars deceptive advertising: objective claims need a reasonable basis before they run, and qualifications and material terms must be clear and conspicuous so the net impression is not misleading.
Unqualified 'Made in USA' and similar claims, including hashtags and seals, require final assembly, all significant processing and all or virtually all components in the U.S.; otherwise claims must be clearly qualified.
Med spa ads for medical aesthetic procedures must not claim no risk, guaranteed or permanent results, or imply prescription drugs need no evaluation, and must be accurate about who performs procedures.
FDA recommends that consumer-directed prescription drug promotion stating efficacy or risk numbers give absolute frequencies for the drug and control groups, use consistent formats, and avoid relative-only figures that overstate benefit.
Request a free compliance scan of your homepage and book a time with Warrant.